Spain v Boehringer Ingelheim Pharmaceuticals, Inc., et al
| Donald Spain |
| Appco Pharma LLC, Dr. Reddy's Laboratories Inc., GlaxoSmithKline LLC, Sanofi US Services Inc., Boehringer Ingelheim USA Corporation, Pfizer Inc., Sanofi-Aventis U.S. LLC, Glenmark Pharmacueticals, Inc. USA, Teva Pharmaceuticals U.S.A., Inc., Granules USA, Inc., Ajanta Pharma USA Inc., Golden State Medical Supply, Inc., GlaxoSmithKline (America) Inc., Boehringer Ingelheim Corporation, Wockhardt USA LLC, Boehringer Ingelheim Pharmaceuticals, Inc., Wockhardt USA, Inc., Amneal Pharmaceuticals of New York, LLC, L. Perrigo Co., Mylan Pharmaceuticals, Inc., Wal-Mart, Novitium Pharma LLC, Geri-Care Pharmaceuticals Corp., Ranbaxy, Inc., Par Pharmaceutical Inc., Sun Pharmaceutical Industries, Inc., Strides Pharma, Inc., Apotex Corporation, Aurobindo Pharma USA, Inc., Sandoz Inc. and Denton Pharma Inc. doing business as Northwind Pharmaceuticals |
| 9:2020cv82220 |
| December 4, 2020 |
| US District Court for the Southern District of Florida |
| Bruce E Reinhart |
| Robin L Rosenberg |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 31, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 4
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Closing Case. Signed by Judge Robin L. Rosenberg on 12/30/2020. See attached document for full details. (pes)
|
| Filing 3 MDL Tag-Along Case Receipt from Southern District of Florida. Case Number 9:20-cv-82220-RLR with documents 1-2. Re: FLSD MDL Case Number 9:20-md-02924-RLR. (mc) |
| Cases associated 9:20-md-2924-RLR. (mc) |
| Filing 2 Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg and Magistrate Judge Bruce E. Reinhart. Pursuant to 28 USC 636(c), the parties are hereby notified that the U.S. Magistrate Judge Bruce E. Reinhart is available to handle any or all proceedings in this case. If agreed, parties should complete and file the Consent form found on our website. It is not necessary to file a document indicating lack of consent. Pro se (NON-PRISONER) litigants may receive Notices of Electronic Filings (NEFS) via email after filing a Consent by Pro Se Litigant (NON-PRISONER) to Receive Notices of Electronic Filing. The consent form is available under the forms section of our website. (jbs) |
| Filing 1 COMPLAINT against Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Boehringer Ingelheim Corporation, GlaxoSmithKline LLC, GlaxoSmithKline (America) Inc., Pfizer Inc., Sanofi-Aventis U.S. LLC, Sanofi US Services Inc., Ajanta Pharma USA Inc., Amneal Pharmaceuticals of New York, LLC, Apotex Corporation, Appco Pharma LLC, Aurobindo Pharma USA, Inc., Dr. Reddy's Laboratories Inc., Glenmark Pharmacueticals, Inc. USA, Novitium Pharma LLC, Par Pharmaceutical Inc., Ranbaxy, Inc., Sandoz Inc., Strides Pharma, Inc., Sun Pharmaceutical Industries, Inc., Teva Pharmaceuticals U.S.A., Inc., Wockhardt USA, Inc., Wockhardt USA LLC, Denton Pharma Inc. d/b/a Northwind Pharmaceuticals, Golden State Medical Supply, Inc., Mylan Pharmaceuticals, Inc., Granules USA, Inc., L. Perrigo Co., Geri-Care Pharmaceuticals Corp., Wal-Mart. Filing fees $ 402.00 receipt number AFLSDC-13978739, filed by Donald Spain. (Attachments: #1 Civil Cover Sheet)(Vanden Brink, Jessica) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
